Bleomycin (BLM) is a glycopeptide anticancer drug capable of effecting single- and double-strand DNA cleavage. The last detectable intermediate prior to DNA cleavage is a low spin Fe III peroxy level ...
New Applications, including Volume Imaging and Fat Suppression, are key to new era of HD MR imaging Dubai, UAE; January 29, 2008: GE Healthcare, the US$17 billion healthcare business of General ...